OTLK — Outlook Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Outlook Therapeutics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th	2025 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	14.5	17.4	23.4	14.9	8.08
Net Total Accounts Receivable
Net Total Receivables	—	—	—	—	1.49
Total Inventory
Prepaid Expenses
Total Current Assets	21.5	27.5	31	27.4	17.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.275	0.07	0.026	0.275	0.226
Long Term Investments
Other Long Term Assets
Total Assets	22.8	28.5	32.3	28.8	18.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6.75	19.7	46.7	42.6	45.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	18.2	19.8	46.7	102	50.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	4.61	8.74	-14.4	-73.1	-32.2
Total Liabilities & Shareholders' Equity	22.8	28.5	32.3	28.8	18.6
Total Common Shares Outstanding
Total Preferred Shares Outstanding